Expansion of the U.S. medical device business through the acquisition of EVAHEART, INC. as a subsidiary
First written in FY2019. 4 of 5 entries say "Worsened", first in FY2020. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024WorsenedAnnual report
「Provision for doubtful accounts Evaheart, Inc. 461」
A ¥461 million provision for doubtful accounts was recorded for EVAHEART, INC. Following its acquisition as a subsidiary in 2019, concerns regarding the recoverability of receivables have emerged in addition to the loss on valuation of shares. - FY2023WorsenedAnnual report
「The loss on valuation of investments in affiliates resulted from impairment losses recognized on shares of the subsidiary 株式会社ハイレックス宮城, Evaheart, Inc. and the associate 株式会社イノフィス.」
A ¥156 million loss on valuation of investments in affiliates was recognized for EVAHEART, INC., indicating that the deterioration in the investment valuation following its acquisition as a subsidiary in the U.S. medical device business has continued. - FY2022WorsenedAnnual report
「The loss on valuation of investments in affiliates resulted from impairment losses recognized on shares of the subsidiaries クリスメディカルソリューションズ株式会社, 株式会社サンメディカル技術研究所, HI-LEX CABLE SYSTEM CO., LTD. and Evaheart, Inc.」
A ¥97 million loss on valuation of investments in affiliates was recognized for Evaheart, Inc., which was made a subsidiary in 2019. The deterioration in investment valuations has continued alongside the expansion of the U.S. medical device business following the acquisition. - FY2020WorsenedAnnual report
「The loss on valuation of investments in affiliates resulted from impairment losses recognized on shares of the subsidiaries HI-LEX CABLE SYSTEM CO., LTD., HI-LEX EUROPE GMBH and Evaheart, Inc.」
Impairment losses were recognized on investments in affiliates in Evaheart, Inc., which was made a subsidiary in 2019 to expand the U.S. medical device business. The deterioration in investment valuations has been added to the theme of expanding the business platform following the acquisition. - FY2019First statedAnnual report
「September 2019: Accepted a third-party allotment of shares by EVAHEART, INC. of Houston, Texas, and made it a subsidiary.」
The fact that the company accepted a third-party allotment of shares by EVAHEART, INC. in the United States and made it a subsidiary is disclosed for the first time.